Chwilio Deddfwriaeth

Council Directive 98/57/ECDangos y teitl llawn

Council Directive 98/57/EC of 20 July 1998 on the control of Ralstonia solanacearum (Smith) Yabuuchi et al.

 Help about what version

Pa Fersiwn

 Help about advanced features

Nodweddion Uwch

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

Mae hon yn eitem o ddeddfwriaeth sy’n deillio o’r UE

Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3

Status:

EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.

[F1Appendix 6 Validated PCR protocols and reagents

NB: Preliminary testing should permit reproducible detection of 10 3 to 10 4 cells of R. solanacearum per ml of sample extract. U.K.

Preliminary testing should also show no false positive results with a panel of selected bacterial strains (see Appendix 3).

1. PCR protocol of Seal et al. (1993) U.K.

1.1. Oligonucleotide primers U.K.
Forward primer OLI-1 5′-GGG GGT AGC TTG CTA CCT GCC-3′
Reverse primer Y-2 5′-CCC ACT GCT GCC TCC CGT AGG AGT-3′

Expected amplicon size from R. solanacearum template DNA = 288 bp

1.2. PCR reaction mix U.K.
a

Method was validated using Taq polymerase from Perkin Elmer (AmpliTaq) and Gibco BRL.

Reagent Quantity per reaction Final concentration
Sterile UPW 17,65 µl
10X PCR buffer a (15 mM MgCl 2 ) 2,5 µl 1X (1,5 mM MgCl 2 )
dNTP mix (20 mM) 0,25 µl 0,2 mM
Primer OLI-1 (20 µM) 1,25 µl 1µM
Primer Y-2 (20 µM) 1,25 µl 1µM
Taq polymerase (5U/µl) a 0,1 µl 0,5 U
Sample volume 2,0 µl
Total volume 25 µl
1.3. PCR reaction conditions U.K.

Run the following programme:

1 cycle of: (i) 2 minutes at 96 °C (denaturation of template DNA)
35 cycles of: (ii) 20 seconds at 94 °C (denaturation of template DNA)
(iii) 20 seconds at 68 °C (annealing of primers)
(iv) 30 seconds at 72 °C (extension of copy)
1 cycle of: (v) 10 minutes at 72 °C (final extension)
(vi) hold at 4 °C.

NB: This programme was optimised for use with a Perkin Elmer 9600 thermal cycler. Modification of the duration steps of cycles (ii), (iii) and (iv) may be required for use with other models. U.K.

1.4. Restriction enzyme analysis of amplicon. U.K.

PCR products amplified from R. solanacearum DNA produce a distinctive restriction fragment length polymorphism with enzyme Ava II after incubation at 37 °C.

2. PCR protocol of Pastrik and Maiss (2000) U.K.

2.1. Oligonucleotide primers U.K.
Forward primer Ps-1 5′- agt cga acg gca gcg ggg g -3′
Reverse primer Ps-2 5′- ggg gat ttc aca tcg gtc ttg ca -3′

Expected amplicon size from R. solanacearum template DNA = 553 bp.

2.2. PCR reaction mix U.K.
a

Methods were validated using Taq polymerase from Perkin Elmer (AmpliTaq) and Gibco BRL.

N.B. Originally optimised for MJ Research PTC 200 thermocycler with Gibco Taq Polymerase.

Perkin Elmer AmpliTaq and buffer can also be used at the same concentrations.

Reagent Quantity per reaction Final concentration
Sterile UPW 16,025 µl
10X PCR buffer a 2,5 µl 1X (1,5 mM MgCl 2 )
BSA (fraction V) (10 %) 0,25 µl 0,1 %
d-nTP mix (20 mM) 0,125 µl 0,1 mM
Primer Ps-1 (10 µM) 0,5 µl 0,2 µM
Primer Ps-2 (10 µM) 0,5 µl 0,2 µM
Taq polymerase (5U/µl) a 0,1 µl 0,5 U
Sample volume 5,0 µl
Total volume: 25,0 µl
2.3. PCR reaction conditions U.K.

Run the following programme:

1 cycle of: (i) 5 minutes at 95 °C (denaturation of template DNA)
35 cycles of: (ii) 30 seconds at 95 °C (denaturation of template DNA)
(iii) 30 seconds at 68 °C (annealing of primers)
(iv) 45 seconds at 72 °C (extension of copy)
1 cycle of: (v) 5 minutes at 72 °C (final extension)
(vi) hold at 4 °C.

NB: This programme is optimised for use with an MJ Research PTC 200 thermal cycler. Modification of the duration steps of cycles (ii), (iii) and (iv) may be required for use with other models. U.K.

2.4. Restriction enzyme analysis of amplicon. U.K.

PCR products amplified from R. solanacearum DNA produce a distinctive restriction fragment length polymorphism with enzyme Taq I after incubation at 65 °C for 30 minutes. The restriction fragments obtained from R. solanacearum -specific fragment are 457 bp and 96 bp in size.

3. Multiplex PCR protocol with internal PCR control (Pastrik et al. , 2002) U.K.

3.1. Oligonucleotide primers U.K.
Forward primer RS-1-F 5′- ACT AAC GAA GCA GAG ATG CAT TA -3′
Reverse primer RS-1-R 5′- CCC AGT CAC GGC AGA GAC T -3′
Forward primer NS-5-F 5′- AAC TTA AAG GAA TTG ACG GAA G -3′
Reverse primer NS-6-R 5′- GCA TCA CAG ACC TGT TAT TGC CTC -3′

Expected amplicon size from R. solanacearum template DNA = 718 bp (RS-primer set)

Expected amplicon size from the 18S rRNA internal PCR control = 310 bp (NS-primer set).

3.2. PCR reaction mix U.K.
a

Methods were validated using Taq polymerase from Perkin Elmer (AmpliTaq) and Gibco BRL.

b

Concentration of primers NS-5-F and NS-6-R were optimised for potato heel end core extraction using the homogenisation method and DNA purification according to Pastrik (2000) (see Section VI.A.6.1.a.). Re-optimisation of reagent concentrations will be required if extraction by shaking or other DNA isolation methods are used.

Reagent Quantity per reaction Final concentration
Sterile UPW 12,625 µl
10X PCR buffer a (15 mM MgCl 2 ) 2,5 µl 1X (1,5 mM MgCl 2 )
BSA (fraction V) (10 %) 0,25 µl 0,1 %
d-nTP mix (20 mM) 0,125 µl 0,1 mM
Primer RS-1-F (10 µM) 2,0 µl 0,8 µM
Primer RS-1-R (10 µM) 2,0 µl 0,8 µM
Primer NS-5-F (10 µM) b 0,15 µl 0,06 µM
Primer NS-6-R (10 µM) b 0,15 µl 0,06 µM
Taq polymerase (5 U/µl) a 0,2 µl 1,0 U
Sample volume 5,0 µl
Total volume: 25,0 µl
3.3. PCR reaction conditions U.K.

Run the following programme:

1 cycle of: (i) 5 minutes at 95 °C (denaturation of template DNA)
35 cycles of: (ii) 30 seconds at 95 °C (denaturation of template DNA)
(iii) 30 seconds at 58 °C (annealing of primers)
(iv) 45 seconds at 72 °C (extension of copy)
1 cycle of: (v) 5 minutes at 72 °C (final extension)
(vi) hold at 4 °C.

NB: This programme is optimised for use with an MJ Research PTC 200 thermal cycler. Modification of the duration steps of cycles (ii), (iii) and (iv) may be required for use with other models. U.K.

3.4. Restriction enzyme analysis of amplicon. U.K.

PCR products amplified from R. solanacearum DNA produce a distinctive restriction fragment length polymorphism with enzyme Bsm I or an Isoschizomere (e.g. Mva 1269 I) after incubation at 65 °C for 30 minutes.

4. R. solanacearum biovar-specific PCR protocol (Pastrik et al. , 2001) U.K.

4.1. Oligonucleotide primers U.K.
Forward primer Rs-1-F 5′- ACT AAC GAA GCA GAG ATG CAT TA -3′
Reverse primer Rs-1-R 5′- CCC AGT CAC GGC AGA GAC T -3′
Reverse primer Rs-3-R 5′- TTC ACG GCA AGA TCG CTC -3′

Expected amplicon size from R. solanacearum template DNA:

with Rs-1-F/Rs-1-R = 718 bp

with Rs-1-F/Rs-3-R = 716 bp.

4.2. PCR reaction mix U.K.
(a)

Biovar 1/2-specific PCR

a

Methods have been validated using Taq polymerase from Perkin Elmer (AmpliTaq) and Gibco BRL.

Reagent Quantity per reaction Final concentration
Sterile UPW 12,925 µl
10X PCR Buffer a 2,5 µl 1X (1,5 mM MgCl 2 )
BSA (fraction V) (10 %) 0,25 µl 0,1 %
d-NTP mix (20mM) 0,125 µl 0,1 mM
Primer Rs-1-F (10 µM) 2 µl 0,8 µM
Primer Rs-1-R (10 µM) 2 µl 0,8 µM
Taq polymerase (5U/µl) a 0,2 µl 1 U
Sample volume 5,0 µl
Total volume 25,0 µl
(b)

Biovar 3/4/5-specific PCR

a

Methods have been validated using Taq polymerase from Perkin Elmer (AmpliTaq) and Gibco BRL.

Reagent Quantity per reaction Final concentration
Sterile UPW 14,925 µl
10X PCR Buffer a 2,5 µl 1X (1,5 mM MgCl 2 )
BSA (fraction V) (10 %) 0,25 µl 0,1 %
dNTP mix (20 mM) 0,125 µl 0,1 mM
Primer Rs-1-F (10 µM) 1 µl 0,4 µM
Primer Rs-3-R (10 µM) 1 µl 0,4 µM
Taq polymerase (5 U/µl) a 0,2 µl 1 U
Sample volume 5,0 µl
Total volume 25,0 µl
4.3. PCR reaction conditions U.K.

Run the following programme for both biovar 1/2- and biovar 3/4/5-specific reactions:

1 cycle of: (i) 5 minutes at 95 °C (denaturation of template DNA)
35 cycles of: (ii) 30 seconds at 95 °C (denaturation of template DNA)
(iii) 30 seconds at 58 °C (annealing of primers)
(iv) 45 seconds at 72 °C (extension of copy)
1 cycle of: (v) 5 minutes at 72 °C (final extension)
(vi) hold at 4 °C.

NB: This programme was optimised for use with an MJ Research PTC 200 thermal cycler. Modification of the duration steps of cycles (ii), (iii) and (iv) may be required for use with other models. U.K.

4.4. Restriction enzyme analysis of amplicon. U.K.

PCR products amplified from R. solanacearum DNA using primers Rs-1-F and Rs-1-R produce a distinctive restriction fragment length polymorphism with enzyme Bsm I or an Isoschizomere (e.g. Mva 1269 I) after incubation at 65 °C for 30 minutes. PCR products amplified from R. solanacearum DNA using primers Rs-1-F and Rs-3-R have no restriction sites.

5. Preparation of the loading buffer U.K.

5.1. Bromphenol blue (10 %- stock solution ) U.K.
Bromphenol blue 5 g
Distilled water (bidest) 50 ml
5.2. Loading buffer U.K.
Glycerol (86 %) 3,5 ml
Bromphenol blue (5,1) 300 µl
Distilled Water (bidest) 6,2 ml

6. 10X Tris Acetate EDTA (TAE) buffer, pH 8.0 U.K.

Tris buffer 48,40 g
Glacial acetic acid 11,42 ml
EDTA (disodium salt) 3,72 g
Distilled water 1,00 L

Dilute to 1X before use.

Also commercially available (e.g. Invitrogen or equivalent).]

Yn ôl i’r brig

Options/Help

Print Options

You have chosen to open the Whole Directive

The Whole Directive you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

Y Rhestrau you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Mae deddfwriaeth ar gael mewn fersiynau gwahanol:

Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.

Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

Gweler y wybodaeth ychwanegol ochr yn ochr â’r cynnwys

Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Dewisiadau Agor

Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd

Close

Rhagor o Adnoddau

Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted version that was used for the EU Official Journal
  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • pob fformat o’r holl ddogfennau cysylltiedig
  • slipiau cywiro
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Close

Llinell Amser Newidiadau

Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.

Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.

Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.

Close

Rhagor o Adnoddau

Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted fersiwn a ddefnyddiwyd am y copi print
  • slipiau cywiro

liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys

  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill